Original Research ARTICLE
IRAK4 and TLR3 sequence variants may alter breast cancer risk among African-American women
- 1Department of Biology, Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, NC, USA
- 2Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA
- 3Winship Cancer Institute, Emory School of Medicine, Emory University, Atlanta, GA, USA
Mounting evidence suggests that imbalances in immune regulation contribute to cell transformation. Women of African descent are an understudied group at high risk for developing aggressive breast cancer (BrCa). Therefore, we examined the role of 16 innate immune single nucleotide polymorphisms (SNPs) in relation to BrCa susceptibility among 174 African-American women in Atlanta, GA, USA. SNPs were examined in germ-line DNA collected from 102 BrCa patients and 72 women with benign nodules using SNPstream methodology. Inheritance of the TLR3 rs10025405 GG genotype was associated with an 82% decrease in BrCa risk. In contrast, individuals who possessed at least one IRAK4 rs4251545 T allele had a 1.68- to 4.99-fold increase in the risk of developing BrCa relative to those with the referent genotype (OR = 4.99; 95% CI = 1.00, 25.00; p = 0.0605). However, the IRAK4 rs4251545 locus was only significant under the additive genetic model (p trend = 0.0406). In silico predictions suggest IRAK4 rs4251545 SNP falls within a transcription enhancer/silencer region of the gene and codes for an Ala428Thr amino acid change. This missense mutation introduces a potential phosphorylation site in the extreme carboxy terminus (XCT) of the IRAK4 kinase domain. Preliminary molecular modeling predicts that this SNP stabilizes two alpha helices within the XCT on the surface of the IRAK4 kinase domain and increases the size of the groove between them. Our in silico results, combined with previous reports noting the presence of IRAK4 and XCT fragments in mouse and human serum, suggest the possibility that the XCT subdomain of IRAK4 possesses biological function. These findings require further evaluation and validation in larger populations, additional molecular modeling as well as functional studies to explore the role of IRAK4 and its XCT in cell transformation and innate immunity.
Keywords: breast cancer, innate immunity, single nucleotide polymorphism, TLR3, IRAK4, African-American, XCT subdomain, extracellular kinase
Citation: Yeyeodu ST, Kidd LR, Oprea-Ilies GM, Burns BG, VanCleave TT, Shim J-Y and Kimbro KS (2013) IRAK4 and TLR3 sequence variants may alter breast cancer risk among African-American women. Front. Immunol. 4:338. doi: 10.3389/fimmu.2013.00338
Received: 23 July 2013; Accepted: 03 October 2013;
Published online: 29 October 2013.
Edited by:Claudia Kemper, King’s College London, UK
Reviewed by:Claudia Kemper, King’s College London, UK
Janos G. Filep, University of Montreal, Canada
Copyright: © 2013 Yeyeodu, Kidd, Oprea-Ilies, Burns, VanCleave, Shim and Kimbro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: K. Sean Kimbro, Department of Biology, Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, 700 George Street, Durham, NC 27707, USA e-mail: email@example.com
†Susan T. Yeyeodu and LaCreis R. Kidd have contributed equally to this work.